Reversine
Reversine is a small synthetic molecule that has been shown to have the ability to dedifferentiate cells, or revert them back to a more primitive state. This molecule was first described in 2004 by a team of researchers at the Scripps Research Institute in California.
History[edit | edit source]
Reversine was first synthesized and described in 2004 by a team of researchers at the Scripps Research Institute in California. The team was led by Peter G. Schultz, a chemist and biologist known for his work in the field of chemical biology. The discovery of reversine was part of a larger project aimed at developing small molecules that could be used to control cell fate.
Mechanism of Action[edit | edit source]
Reversine works by inhibiting the activity of certain protein kinases, enzymes that are involved in regulating cell division and differentiation. Specifically, it has been shown to inhibit the activity of Aurora kinases and Polo-like kinase 1, both of which are involved in the process of cell division. By inhibiting these kinases, reversine is able to induce cells to revert back to a more primitive state, a process known as dedifferentiation.
Potential Applications[edit | edit source]
The ability of reversine to induce dedifferentiation has led to interest in its potential use in regenerative medicine. For example, it could potentially be used to convert differentiated cells, such as skin cells, back into stem cells, which could then be used to regenerate damaged or diseased tissues. However, much more research is needed to fully understand the potential applications and limitations of reversine.
Safety and Side Effects[edit | edit source]
As with any drug, the safety and potential side effects of reversine are important considerations. While reversine has been shown to be relatively safe in laboratory studies, it has not yet been tested in humans. Therefore, the potential side effects and long-term safety of reversine are not yet known.
See Also[edit | edit source]
References[edit | edit source]
| Reversine Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
